 The SYNTAX trial is designed to determine the best treatment for patients with complex coronary disease blocked or narrowed arteries in both the right and left sides of the heart by randomizing patients to receive either percutaneous coronary intervention PCI with polymer-based paclitaxel-eluting TAXUS stents or to coronary artery bypass surgery CABG. 